findmyKOL

Zujaja Tauqeer, MD, DPHIL

Basic profile

Beaumont Health

ORCID↗NPI↗
✓ Full record
RegionCincinnati, OH · MidwestSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL type: RegionalLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Zujaja Tauqeer is an Ophthalmology physician affiliated with Beaumont Health. OpenAlex indexes 37 publications with 830 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
37publications

Distinct works indexed by OpenAlex, matched via ORCID.

830citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
17companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3333 Burnet Ave
Cincinnati, OH 452293026

Telephone

513-636-4225

Provider last certified this registry record 21 Nov 2024.

View the NPPES registry record

Industry payments

17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    93.8%
    Antineovascularisation agents74.9%
    Faricimab-svoa100%
    Part B, office-administered≥12 patients
    Corticosteroid9.2%
    Prednisolone Acetate100%
    Part D≥133 patients

    + 6 more classes in this area

  • Cancer & immunology

    4.7%
    Vascular Endothelial Growth Factor Inhibitor4.7%
    Aflibercept100%
    Part B, office-administered≥33 patients
  • Musculoskeletal

    1.5%
    Cyclooxygenase Inhibitor1.5%
    Ketorolac Tromethamine100%
    Part D≥17 patients
Where care is delivered (Part B)4.2% facility · 95.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”